Increased leptin and A-FABP levels in relapsing and progressive forms of MS

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Messina, Silvia ^a,b   Vargas Lowy, David ^a   Musallam, Alexander ^a   Healy, Brian C ^a,c   Kivisakk, Pia ^a   Gandhi, Roopali ^a   Bove, Riley ^a   Gholipour, Taha ^a   Khoury, Samia ^a   Weiner, Howard L ^a   Chitnis, Tanuja ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

132. Autoimmune disease; 175. Neuroendocrinology; 41. multiple sclerosis

Indexed keywords

FATTY ACID BINDING PROTEIN 4; LEPTIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PROTEIN BLOOD LEVEL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; MIDDLE AGED;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84887150106     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-172     Document Type: Article

References (37)

1. Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008, 255(Suppl 1):3-11.
2. Ouchi N, Ohashi K, Shibata R, Murohara T. Adipocytokines and obesity-linked disorders. Nagoya J Med Sci 2012, 74:19-30.
3. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology 2009, 73:1543-1550. 10.1212/WNL.0b013e3181c0d6e0, 2777074, 19901245.
4. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783. 10.1038/nri1937, 16998510.
5. Sanna V, Di Giacomo A, La Cava A, et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Investig 2003, 111:241-250. 151876, 12531880.
6. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004, 4:371-379. 10.1038/nri1350, 15122202.
7. Chatzantoni K, Papathanassopoulos P, Gourzoulidou E, Mouzaki A. Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients. J Autoimmun 2004, 23:169-177. 10.1016/j.jaut.2004.05.007, 15324935.
8. Batocchi AP, Rotondi M, Caggiula M, et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003, 139:150-154. 10.1016/S0165-5728(03)00154-1, 12799033.
9. Angelucci F, Mirabella M, Caggiula M, et al. Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis. Peptides 2005, 26:2289-2293. 10.1016/j.peptides.2005.03.037, 16269354.
10. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 2005, 25:1220-1224. 10.1161/01.ATV.0000159163.52632.1b, 15705927.
11. Tso AW, Lam TK, Xu A, et al. Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology 2011, 76:1968-1975. 10.1212/WNL.0b013e31821e54b3, 21562251.
12. Gauthier SA, Glanz BI, Mandel M, Weiner HL. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun Rev 2006, 5:532-536. 10.1016/j.autrev.2006.02.012, 17027888.
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.
14. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68:S7-S12. 10.1212/01.wnl.0000259422.44235.a8, 17438241.
15. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009, 66:54-59. 10.1001/archneurol.2008.505, 19139299.
16. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS 2000, xvi-528. New York: Springer.
17. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998, 68:899-917. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US).
18. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. Jama. 2012, 307:491-497. 10.1001/jama.2012.39, 22253363.
19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. 10.1038/372425a0, 7984236.
20. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770. 10.1038/27376, 9796811.
21. Matarese G, Procaccini C, De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?. J Leukoc Biol 2008, 84:893-899. 10.1189/jlb.0108022, 18552206.
22. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901. 10.1038/29795, 9732873.
23. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. Faseb J. 1998, 12:57-65.
24. Matarese G, Di Giacomo A, Sanna V, et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001, 166:5909-5916.
25. Komori M, Matsuyama Y, Nirasawa T, et al. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann Neurol 2012, 71:614-623. 10.1002/ana.22633, 22522477.
26. Frisullo G, Mirabella M, Angelucci F, et al. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007, 192:174-183. 10.1016/j.jneuroim.2007.08.008, 17904647.
27. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006, 47:39-48. 10.1007/BF03194597, 16424607.
28. Xu A, Tso AW, Cheung BM, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007, 115:1537-1543. 10.1161/CIRCULATIONAHA.106.647503, 17389279.
29. Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 2013
30. Hui X, Li H, Zhou Z, et al. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem 2010, 285:10273-10280. 10.1074/jbc.M109.097907, 2856232, 20145251.
31. Reynolds JM, Liu Q, Brittingham KC, et al. Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J Immunol 2007, 179:313-321.
32. Kiess W, Muller G, Galler A, et al. Body fat mass, leptin and puberty. J Pediatr Endocrinol Metab 2000, 13(Suppl 1):717-722.
33. Quennell JH, Mulligan AC, Tups A, et al. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology 2009, 150:2805-2812. 10.1210/en.2008-1693, 2732287, 19179437.
34. Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012, 18:1334-1336. 10.1177/1352458512436596, 22328681.
35. Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 2013, 80:548-552. 10.1212/WNL.0b013e31828154f3, 23365063.
36. Lee K, Santibanez-Koref M, Polvikoski T, Birchall D, Mendelow AD, Keavney B. Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture. Atherosclerosis 2013, 226:74-81. 10.1016/j.atherosclerosis.2012.09.037, 3566542, 23122912.
37. Simon C, Gronfier C, Schlienger JL, Brandenberger G. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab 1998, 83:1893-1899. 10.1210/jc.83.6.1893, 9626115.